Loncastuximab tesirine with rituximab in patients with relapsed or refractory follicular lymphoma: a single-centre, single-arm, phase 2 trial.
Alderuccio JP, Alencar AJ, Schatz JH, Kuker RA, Pongas G, Reis IM, Lekakis LJ, Spiegel JY, Sandoval-Sus J, Beitinjaneh A, Stanchina MD, Trabolsi A, Lossos IS, Rosenblatt JD, Lessen DS, Moskowitz CH.
Alderuccio JP, et al. Among authors: reis im.
Lancet Haematol. 2024 Dec 6:S2352-3026(24)00345-4. doi: 10.1016/S2352-3026(24)00345-4. Online ahead of print.
Lancet Haematol. 2024.
PMID: 39662486